SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer

S Suresh, D Durakoglugil, X Zhou, B Zhu… - PLoS …, 2017 - journals.plos.org
Hepatocellular carcinoma (HCC) is the fifth most common solid tumor in the world and the
third leading cause of cancer-associated deaths. A Sleeping Beauty-mediated transposon …

A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer

KA O'Donnell, VW Keng, B York… - Proceedings of the …, 2012 - National Acad Sciences
The Sleeping Beauty (SB) transposon mutagenesis system is a powerful tool that facilitates
the discovery of mutations that accelerate tumorigenesis. In this study, we sought to identify …

Steroid receptor coactivator 1 promotes human hepatocellular carcinoma progression by enhancing Wnt/β-catenin signaling

Z Tong, M Li, W Wang, P Mo, L Yu, K Liu, W Ren… - Journal of Biological …, 2015 - ASBMB
Steroid receptor coactivator 1 (SRC-1) is a transcriptional coactivator not only for steroid
receptors, such as androgen receptor and estrogen receptor, but also for other transcription …

Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation

S Wang, Y Yuan, L Liao, SQ Kuang… - Proceedings of the …, 2009 - National Acad Sciences
Steroid receptor coactivator-1 (SRC-1) is a coactivator for nuclear hormone receptors such
as estrogen and progesterone receptors and certain other transcription factors such as Ets-2 …

c-Myc-driven Hepatocarcinogenesis

H Moon, H Park, SW Ro - Anticancer Research, 2021 - ar.iiarjournals.org
Background/Aim: Dysregulation of the c-Myc gene is frequently found in human
hepatocellular carcinoma (HCC), often accompanied by genetic and epigenetic alterations …

SRC-3 is required for prostate cancer cell proliferation and survival

HJ Zhou, J Yan, W Luo, G Ayala, SH Lin, H Erdem… - Cancer research, 2005 - AACR
Prostate cancer is the most common cancer in men in America. Currently, steroid receptor
coactivators have been proposed to mediate the development and progression of prostate …

SCARB2 drives hepatocellular carcinoma tumor initiating cells via enhanced MYC transcriptional activity

F Wang, Y Gao, S Xue, L Zhao, H Jiang… - Nature …, 2023 - nature.com
CSCs (Cancer stem cells) with distinct metabolic features are considered to cause HCC
(hepatocellular carcinoma) initiation, metastasis and therapeutic resistance. Here, we …

Targeting the yin and the yang: combined inhibition of the tyrosine kinase c-Src and the tyrosine phosphatase SHP-2 disrupts pancreatic cancer signaling and biology …

EG Gomes, SF Connelly, JM Summy - Pancreas, 2013 - journals.lww.com
Objectives Although c-Src (Src) has emerged as a potential pancreatic cancer target in
preclinical studies, Src inhibitors have not demonstrated a significant therapeutic benefit in …

[HTML][HTML] Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis

A Cigliano, MG Pilo, L Li, G Latte, M Szydlowska… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Deregulated activity of the c-Myc protooncogene is a frequent molecular event underlying
mouse and human hepatocarcinogenesis. Nonetheless, the mechanisms sustaining c-Myc …

Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma

A Deutzmann, DK Sullivan, R Dhanasekaran… - Nature …, 2024 - nature.com
The MYC oncogene is often dysregulated in human cancer, including hepatocellular
carcinoma (HCC). MYC is considered undruggable to date. Here, we comprehensively …